Quality of life in adults and older adults with Chagas disease
DOI:
https://doi.org/10.24220/2318-0897v24n3a2654Palavras-chave:
Aged. Chagas disease. Quality of life.Resumo
Objective
The objective was to evaluate the perceived quality of life of adult and older adult patients with different clinical forms of Chagas disease.
Methods
This descriptive and cross-sectional research was conducted between 2005 and 2008. Data were collected from 202 patients. The World Health Organization Quality of Life-
-BREF was used to assess the quality of life domains. Statistical analyses included descriptive analysis, and univariate and multivariate logistic regression analyses.
Results
Of the 202 interviewed patients, 53.96% were female; 68.81% were aged £60 years, 66.83% presented the cardiac form, 11.39% presented the digestive form, and 21.78% had the indeterminate form. Patients with the cardiac and digestive forms were more likely to report lower quality of life in the physical, psychological, and social relationships domains than those with the indeterminate form. In the environment domain, women and those with more comorbidities had lower scores.
Conclusion
The social relationships domain received the highest scores, followed by the psychological and physical domains. The environment domain received the lowest scores. Comparing the scores of the World Health Organization Quality of Life-BREF domains by age group (adults and older adults) in relation to the clinical form, gender, and number of comorbidities, quality of life did not differ significantly in any of the study subgroups.
Keywords: Aged. Chagas disease. Quality of life.
Downloads
Referências
Guia para vigilância, prevenção, controle e manejo
clínico da doença de Chagas aguda transmitida por
alimentos. Rio de Janeiro: OMS; 2009.
World Health Organization. Working to overcome the
global impact of neglected tropical diseases. First
WHO report on neglected tropical diseases: Working
to overcome the global impact of neglected tropical
diseases. Geneva: WHO Press; 2010.
Silveira AC. Os novos desafios e perspectivas futuras
do controle. Rev Soc Bras Med Trop. 2011; 44(Suppl.
:122-4.
Guariento ME, Alliegro FC, Almeida EA. Doença de
Chagas associada a doenças crônicas em pacientes
assistidos em ambulatório de hospital universitário.
Rev Bras Clin Med. 2009; 7(2):84-8.
Paes NA. A mortalidade por doenças infecciosas e
parasitárias na população idosa brasileira. Rev Panam
Salud Publica. 2004; 15(4):233-41.
Oliveira AP, Gomes LF, Casarin ST, Siqueira HCH. O
viver do portador chagásico crônico: possibilidades
de ações do enfermeiro para uma vida saudável. Rev
Gaúcha Enferm. 2010; 31(3):491-8.
Gontijo ED, Guimarães TN, Magnani C, Paixão GM,
Dupin S, Paixão LM. Qualidade de vida dos portadores
de doença de Chagas . Rev Med Minas Gerais. 2009;
(4):281-5.
Fleck MPA, Louzada S, Xavier M, Chachamovich E,
Vieira G, Santos L, et al. Aplicação da versão em
português do instrumento abreviado de avaliação de
qualidade de vida “WHOQOL-BREF”. Rev Saúde
Pública. 2000; 34(2):178-83.
Brasil. Secretaria do Ministério da Saúde. Consenso
brasileiro em Doença de Chagas. Rev Soc Bras Med
Trop. 2005; 38(Supl. 3):1-29.
Coura JR, Borges-Pereira J. Chronic phase of Chagas
disease: Why should it be treated? A comprehensive
review. Mem Inst Oswaldo Cruz. 2011; 106(6):641-
Almeida EA, Barbosa Neto RM, Guariento ME,
Wanderley JS, Souza ML. Apresentação clínica da
doença de Chagas crônica em indivíduos idosos. Rev
Soc Bras Med Trop. 2007; 40(3):311-5.
Silva GMS, Chambela MC, Sousa AS, Sangenis LHC,
Xavier SS, Costa AR, et al. Impact of pharmaceutical
care on the quality of life of patients with Chagas
Disease and heart failure: Randomized clinical trial.
Trials. 2012; 13(244):1-7.
Lima-Costa MF, Barreto SM, Guerra HL, Firmo JOA,
Uchoa E, Vidigal PG. Ageing with Trypanosoma cruzi
infection in a community where the transmission has
been interrupted: The Bambuí Health and Aging Study
(BHAS). Int J Epidemiol. 2001; 30(4):887-93.
Alves RMA, Thomaz RP, Almeida EA, Wanderley JS,
Guariento ME. Chagas’ disease and ageing: the
coexistence of other chronic diseases with Chagas’ disease in elderly patients. Rev Soc Bras Med Trop.
; 42(6):622-8.
Pérez-Molina JA, Perez AM, Norman FF, Monge-Maillo
B, López-Vélez R. Old and new challenges in Chagas
disease. Lancet Infect Dis. 2015; 15:1347-56.
Sousa GR, Costa HS, Souza AC, Nunes MCP, Lima
MMO, Rocha MOC. Health-related quality of life in
patients with Chagas disease: A review of the
evidence. Rev Soc Bras Med Trop. 2015; 48(2):121-8.
Bozelli CE, Araujo SM, Guilherme ALF, Gomes ML.
Perfil clínico epidemiológico de pacientes com doença
de Chagas no Hospital Universitário de Maringá,
Paraná, Brasil. Cad Saúde Pública. 2006; 22(5):1027-
Ozaki Y, Guariento ME, Almeida EA. Quality of life
and depressive symptoms in Chagas disease patients.
Qual Life Res. 2011; 20(11):133-8.
Oliveira BG, Abreu MNS, Abreu CD, Rocha MOC,
Ribeiro AL. Health-related quality of life in patients
with Chagas disease. Rev Soc Bras Med Trop. 2011;
(2):150-6.
Orosz JEB, Morano FG, Guariento ME. Caracterização
da doença de Chagas quanto à categoria gênero em
um serviço de referência. Rev Bras Clin Ter. 1996; 22:9-
Lima-Costa MF, Castro-Costa E, Uchôa E, Firmo J,
Ribeiro ALP, Ferri CP, et al. A population-based study
of the association between Trypanosoma cruzi
infection and cognitive impairment in old age (The
Bambuí Study). Neuroepidemiology. 2009; 32(2):122-
Uchôa E, Firmo JOA, Dias EC, Pereira MSN, Gontijo
ED. Signos, significados e ações associados à doença
de Chagas. Cad Saúde Pública. 2002; 18(1):71-9.
Hueb MFD, Loureiro SR. Revisão: aspectos cognitivos
e psicossociais associados a doença de Chagas. Psicol
Estud. 2005; 10(1):137-42.
Mota DCGD, Benevides-Pereira AMT, Gomes ML,
Araújo SM. Estresse e resiliência em doença de Chagas
. Aletheia. 2006; 24:57-68.
Rocha MOC, Correia PC, Barros MVL, Torres RM,
Ribeiro ALP, Teixeira MM. Cardiovascular function in
elderly patients with chronic Chagas ic cardiopathy.
Rev Soc Bras Med Trop. 2003; 36(5):545-50.
Villela MM, Souza JB, Mello VP, Azeredo BVM, Dias
JCP. Vigilância epidemiológica da doença de Chaga
na região centro-oeste de Minas Gerais, Brasil, entre
os anos de 2000 e 2003. Cad Saúde Pública. 2005;
(3):878-86.
Coura JR, Borges-Pereira J. Chagas disease. What is
known and what should be improved: A systemic
review. Rev Soc Bras Med Trop. 2012; 45(3):286-96.
Carneiro O, Rezende JM. Doença de Chagas e
longevidade. Arq Bras Cardiol. 1982; 38(5):381-4.
Bertanha L, Guariento ME, Magna LA, Almeida EA.
Caracterização clínico-laboratorial de chagásicos
hipertensos sem insuficiência cardíaca manifesta. Rev
Soc Bras Med Trop. 2008; 41(2):163-8.
Chaimowicz F. A saúde dos idosos brasileiros às
vésperas do século XXI: problemas, projeções e
alternativas. Rev Saúde Pública.1997; 31(2):184-200.
Santo AH. Tendência da mortalidade relacionada à
doença de Chagas , Estado de São Paulo, Brasil, 1985
a 2006: estudo usando causas múltiplas de morte.
Rev Panam Sallud Publica. 2009; 26(4):299-309.
Souza AC, Rocha MOC, Teixeira AL, Dias Júnior JO,
Sousa LAP, Nunes MCP. Depressive symptoms and
disability in Chagas ic stroke patients: Impact on
functionality and quality of life. J Neurol Sci. 2013;
(1-2):34-7.
